Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
28.02
+0.81 (2.98%)
At close: Nov 4, 2025, 4:00 PM EST
28.01
-0.01 (-0.04%)
After-hours: Nov 4, 2025, 7:00 PM EST
Koninklijke Philips Market Cap
Koninklijke Philips has a market cap or net worth of $26.81 billion as of November 4, 2025. Its market cap has decreased by -6.87% in one year.
Market Cap
26.81B
Enterprise Value
34.29B
1-Year Change
-6.87%
Ranking
Category
Stock Price
$28.02
Market Cap Chart
Since December 1, 1998, Koninklijke Philips's market cap has increased from $15.62B to $26.81B, an increase of 71.66%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 25.17B | 9.67% |
| Dec 31, 2024 | 22.95B | 11.60% |
| Dec 29, 2023 | 20.56B | 57.66% |
| Dec 30, 2022 | 13.04B | -60.89% |
| Dec 31, 2021 | 33.35B | -30.89% |
| Dec 31, 2020 | 48.26B | 8.19% |
| Dec 31, 2019 | 44.61B | 37.19% |
| Dec 31, 2018 | 32.52B | -7.46% |
| Dec 29, 2017 | 35.14B | 23.45% |
| Dec 30, 2016 | 28.46B | 19.64% |
| Dec 31, 2015 | 23.79B | -12.24% |
| Dec 31, 2014 | 27.11B | 42.97% |
| Dec 30, 2011 | 18.96B | -31.76% |
| Dec 31, 2010 | 27.79B | 4.28% |
| Dec 31, 2009 | 26.65B | 48.16% |
| Dec 31, 2008 | 17.98B | -53.52% |
| Dec 31, 2007 | 38.69B | 13.76% |
| Dec 29, 2006 | 34.01B | 20.84% |
| Dec 30, 2005 | 28.15B | 17.36% |
| Dec 31, 2004 | 23.99B | -8.90% |
| Dec 31, 2003 | 26.33B | 64.54% |
| Dec 31, 2002 | 16.00B | -39.26% |
| Dec 31, 2001 | 26.35B | -19.70% |
| Dec 29, 2000 | 32.81B | 7.41% |
| Dec 31, 1999 | 30.55B | 83.48% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |